Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
Sue Bacon, VTE specialist – Quality Improvement at North Bristol NHS Trust, reposted from Firstkind Ltd on LinkedIn:
”It’s so important to ask this question – hospital acquired DVT and PE is not uncommon, and sometimes linked to lack of an assessment of your individual risk, but also, sadly, because patients do not understand enough and refuse the medication/devices.
Please, please ask.”
Firstkind Ltd shared on LinkedIn:
”Did you know?
More people die each year in the UK from hospital-acquired venous thromboembolism (VTE) than from breast cancer, AIDS, and traffic accidents combined.
VTE is a leading cause of preventable death in hospitals — yet it’s often overlooked.
The good news? Most cases are entirely preventable with timely risk assessments and appropriate treatment.
Innovative technologies like the geko device, which stimulates blood flow in the lower leg, are helping reduce VTE risk when traditional methods aren’t suitable.
If you or a loved one is admitted to hospital, don’t be afraid to ask: ‘Have I been assessed for blood clots?”
Stay updated with Hemostasis Today.
-
Feb 26, 2026, 15:24Nancy Shapiro: Excited to See This Publication on Current Landscape of Anticoagulation Stewardship Released
-
Feb 26, 2026, 15:15Ahmed Nasreldein: Stay Current on Key Updates in Ischemic and Hemorrhagic Stroke
-
Feb 26, 2026, 15:15Shannon Farmer: What Happens to Vital Signs Pre and Post 1-Unit and 2-Unit RBC Transfusion?
-
Feb 26, 2026, 15:08Emmanuel J Favaloro: When Is A ‘Subtype’ of VWD Not Really VWD?
-
Feb 26, 2026, 15:03Gregory Piazza: Importance of Recognizing PE As A Wide Spectrum of Presentations and Greater Range of Adverse Outcomes
-
Feb 26, 2026, 14:57Abdulla A. Damluji: Sex As An Effect Measure Modifier Between Frailty and Outcomes in AMI Patients
-
Feb 26, 2026, 14:48Ney Carter Borges: The APERITIF Trial Clarifies Rivaroxaban’s Role in LVT
-
Feb 26, 2026, 14:44Wolfgang Miesbach: Synovitis and Haemophilia in Focus at GTH2026
-
Feb 26, 2026, 14:40Al-Ola Abdallah: How Much Does It Cost to Publish in Hematology and Oncology Journals